Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05668481 · ClinicalTrials.gov registry record · NA
Improving Patient Memory for Treatment for Mild Cognitive Impairment
A NA study, sponsored by University of California, Berkeley.
- Completed
- Registry status
- NA
- Development phase
- 119
- Enrollment target
NCT05668481 is a NA study that has completed, run by University of California, Berkeley. The registered enrollment target is 119 participants.
The verdict
NCT05668481, a NA study, has completed, sponsored by University of California, Berkeley.
- COMPLETED
- Registry status
- NA
- Development phase
- 119 participants
- Enrollment target
Study Summary
The main empirical question to be addressed is: What types of memory support are most potent for patients who are experiencing a mild cognitive impairment (MCI) relative to non-MCI patients?
Interventions
- BEHAVIORAL Transdiagnostic sleep and circadian intervention (TranS-C)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2023-05-19 |
| Est. Completion | 2025-06-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05668481
The ClinicalTrials.gov registry entry for NCT05668481 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Berkeley, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transdiagnostic sleep and circadian intervention (TranS-C) is the first listed.
NCT05668481 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05668481 about?
NCT05668481 is a clinical study titled "Improving Patient Memory for Treatment for Mild Cognitive Impairment". The main empirical question to be addressed is: What types of memory support are most potent for patients who are experiencing a mild cognitive impairment (MCI) relative to non-MCI patients?
What is the current status of trial NCT05668481?
This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2023-05-19. Estimated completion is 2025-06-26.
What interventions are being tested in trial NCT05668481?
The interventions under investigation include: Transdiagnostic sleep and circadian intervention (TranS-C) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05668481?
This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.